Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
Jiangsu Bioperfectus Technologies Co Ltd
Cash from Operating Activities
Jiangsu Bioperfectus Technologies Co Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
|
Cash from Operating Activities
¥2B
|
CAGR 3-Years
164%
|
CAGR 5-Years
100%
|
CAGR 10-Years
N/A
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Cash from Operating Activities
¥2.2B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Cash from Operating Activities
¥780.7m
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
17%
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Cash from Operating Activities
¥1.5B
|
CAGR 3-Years
34%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Cash from Operating Activities
¥3B
|
CAGR 3-Years
71%
|
CAGR 5-Years
53%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Cash from Operating Activities
¥1.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
See Also
What is Jiangsu Bioperfectus Technologies Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
2B
CNY
Based on the financial report for Dec 31, 2022, Jiangsu Bioperfectus Technologies Co Ltd's Cash from Operating Activities amounts to 2B CNY.
What is Jiangsu Bioperfectus Technologies Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
100%
Over the last year, the Cash from Operating Activities growth was 99%. The average annual Cash from Operating Activities growth rates for Jiangsu Bioperfectus Technologies Co Ltd have been 164% over the past three years , 100% over the past five years .